COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- An Observational Study on the Use of Manual Muscle Testing for Dietary Elimination in Food Sensitivity-Related Conditions
- The Association Between Perceived Stress, Lifestyle and Dietary Behaviors, and Hypertension Among University Personnel
- Evaluation of Technological Performance of Algerian Soft Wheat Varieties
- Implications of climate-smart aquaculture practices on households’ income and food security in Mwanza and Mara, Tanzania’s Lake Zone
- The Role of Barley, Sorghum, Rice, and Maize in North African Cuisine
- Simultaneous Determination of Acrylamide, Caffeic Acid, and Caffeine in Commercial Coffee Capsules Using a Rapid and Validated HPLC-DAD Approach
- The Impact of Black Chokeberry (Aronia melanocarpa) on Gut Microbiota and Human Health: Systematic Review and Meta-analysis of Randomized Controlled Trials in Humans
- Understanding Bread Consumption and Waste Patterns in Algeria and Tunisia: Insights into Consumer Practices and Challenges
- Hepatorenal and Cerebral Toxicity Induced by Consumption of Cow Meat Singed with Scrap Tyres: An Experimental Study in a Rat Model
- Editorial introduction to the first issue
You may also start an advanced similarity search for this article.

NAJFNR is licensed under